what causes glp 1 release is GLP-1 & Does it Affect Weight & Cognition? GLP-1 | Pancreapedia

This clinical checklist built on Indian BMI thresholds, not Western guidelines tells you exactly what to assess before speaking to your doctor

Lee SJ, Lee J, Li KK, Holland D, Maughan H, Guttman DS, et al

Currently, it is indicated for patients with a BMI greater than 30% or a BMI greater than 27% with comorbidities

However, they noted that these findings need to be verified by studies involving other groups, including those taking GLP-1 drugs for obesity

Hauge, M

Table 7: Results at Week 26 in a Trial Comparing TRESIBA Dosed Once Daily at the Same and at Alternating Times Each Day to Insulin Glargine U-100 in Adult Patients with Type 1 Diabetes Mellitus Receiving Insulin Aspart at Mealtimes Type 1 Diabetes Pediatric Patients 1 Year of Age and Older Study J TRESIBA Administered at the Same Time Each Day in Combination with a Rapid Acting Insulin Analog at Mealtimes in Pediatric Patients 1 Year of Age and Older The efficacy of TRESIBA was evaluated in a 26 week, randomized, open label, multicenter trial in 350 patients with type 1 diabetes mellitus (Study J)